Homehealthcare News

    Novartis nears deal to buy US biotech firm Medicines Co for about $7 billion

    Novartis nears deal to buy US biotech firm Medicines Co for about $7 billion

    Novartis nears deal to buy US biotech firm Medicines Co for about $7 billion
    Profile image

    By Reuters  IST (Published)

    Mini

     Swiss drugmaker Novartis AG is nearing an agreement to acquire US biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday.

    Swiss drugmaker Novartis AG is nearing an agreement to acquire US biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday.
    The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.
    Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    arrow down

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng